Global Asthma Medication Market Research Report 2024

Publication ID:

PB503249066

Publication Date:

March 13, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global Asthma Medication market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Asthma Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Asthma Medication.
Report Scope
The Asthma Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Asthma Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Asthma Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dulera
QVAR
Glaxosmithkline plc
MAP Pharmaceuticals锛孖nc
Merck & Co. Inc
AstraZeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
Theravance Inc
Segment by Type
Quick-Relief Medications
Long-Term Control Medications
Asthma Medications During Pregnancy
Segment by Application
Children
Adolescent
Adult
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Asthma Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Asthma Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Asthma Medication Market Overview
1.1 Product Overview and Scope of Asthma Medication
1.2 Asthma Medication Segment by Type
1.2.1 Global Asthma Medication Market Value Comparison by Type (2024-2030)
1.2.2 Quick-Relief Medications
1.2.3 Long-Term Control Medications
1.2.4 Asthma Medications During Pregnancy
1.3 Asthma Medication Segment by Application
1.3.1 Global Asthma Medication Market Value by Application: (2024-2030)
1.3.2 Children
1.3.3 Adolescent
1.3.4 Adult
1.4 Global Asthma Medication Market Size Estimates and Forecasts
1.4.1 Global Asthma Medication Revenue 2019-2030
1.4.2 Global Asthma Medication Sales 2019-2030
1.4.3 Global Asthma Medication Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Asthma Medication Market Competition by Manufacturers
2.1 Global Asthma Medication Sales Market Share by Manufacturers (2019-2024)
2.2 Global Asthma Medication Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Asthma Medication Average Price by Manufacturers (2019-2024)
2.4 Global Asthma Medication Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Asthma Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Asthma Medication, Product Type & Application
2.7 Asthma Medication Market Competitive Situation and Trends
2.7.1 Asthma Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Asthma Medication Players Market Share by Revenue
2.7.3 Global Asthma Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Asthma Medication Retrospective Market Scenario by Region
3.1 Global Asthma Medication Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Asthma Medication Global Asthma Medication Sales by Region: 2019-2030
3.2.1 Global Asthma Medication Sales by Region: 2019-2024
3.2.2 Global Asthma Medication Sales by Region: 2025-2030
3.3 Global Asthma Medication Global Asthma Medication Revenue by Region: 2019-2030
3.3.1 Global Asthma Medication Revenue by Region: 2019-2024
3.3.2 Global Asthma Medication Revenue by Region: 2025-2030
3.4 North America Asthma Medication Market Facts & Figures by Country
3.4.1 North America Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Asthma Medication Sales by Country (2019-2030)
3.4.3 North America Asthma Medication Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Asthma Medication Market Facts & Figures by Country
3.5.1 Europe Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Asthma Medication Sales by Country (2019-2030)
3.5.3 Europe Asthma Medication Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Asthma Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Asthma Medication Sales by Country (2019-2030)
3.6.3 Asia Pacific Asthma Medication Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Asthma Medication Market Facts & Figures by Country
3.7.1 Latin America Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Asthma Medication Sales by Country (2019-2030)
3.7.3 Latin America Asthma Medication Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Asthma Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Asthma Medication Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Asthma Medication Sales by Country (2019-2030)
3.8.3 Middle East and Africa Asthma Medication Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Asthma Medication Sales by Type (2019-2030)
4.1.1 Global Asthma Medication Sales by Type (2019-2024)
4.1.2 Global Asthma Medication Sales by Type (2025-2030)
4.1.3 Global Asthma Medication Sales Market Share by Type (2019-2030)
4.2 Global Asthma Medication Revenue by Type (2019-2030)
4.2.1 Global Asthma Medication Revenue by Type (2019-2024)
4.2.2 Global Asthma Medication Revenue by Type (2025-2030)
4.2.3 Global Asthma Medication Revenue Market Share by Type (2019-2030)
4.3 Global Asthma Medication Price by Type (2019-2030)
5 Segment by Application
5.1 Global Asthma Medication Sales by Application (2019-2030)
5.1.1 Global Asthma Medication Sales by Application (2019-2024)
5.1.2 Global Asthma Medication Sales by Application (2025-2030)
5.1.3 Global Asthma Medication Sales Market Share by Application (2019-2030)
5.2 Global Asthma Medication Revenue by Application (2019-2030)
5.2.1 Global Asthma Medication Revenue by Application (2019-2024)
5.2.2 Global Asthma Medication Revenue by Application (2025-2030)
5.2.3 Global Asthma Medication Revenue Market Share by Application (2019-2030)
5.3 Global Asthma Medication Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Dulera
6.1.1 Dulera Corporation Information
6.1.2 Dulera Description and Business Overview
6.1.3 Dulera Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Dulera Asthma Medication Product Portfolio
6.1.5 Dulera Recent Developments/Updates
6.2 QVAR
6.2.1 QVAR Corporation Information
6.2.2 QVAR Description and Business Overview
6.2.3 QVAR Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.2.4 QVAR Asthma Medication Product Portfolio
6.2.5 QVAR Recent Developments/Updates
6.3 Glaxosmithkline plc
6.3.1 Glaxosmithkline plc Corporation Information
6.3.2 Glaxosmithkline plc Description and Business Overview
6.3.3 Glaxosmithkline plc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glaxosmithkline plc Asthma Medication Product Portfolio
6.3.5 Glaxosmithkline plc Recent Developments/Updates
6.4 MAP Pharmaceuticals锛孖nc
6.4.1 MAP Pharmaceuticals锛孖nc Corporation Information
6.4.2 MAP Pharmaceuticals锛孖nc Description and Business Overview
6.4.3 MAP Pharmaceuticals锛孖nc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 MAP Pharmaceuticals锛孖nc Asthma Medication Product Portfolio
6.4.5 MAP Pharmaceuticals锛孖nc Recent Developments/Updates
6.5 Merck & Co. Inc
6.5.1 Merck & Co. Inc Corporation Information
6.5.2 Merck & Co. Inc Description and Business Overview
6.5.3 Merck & Co. Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Merck & Co. Inc Asthma Medication Product Portfolio
6.5.5 Merck & Co. Inc Recent Developments/Updates
6.6 AstraZeneca plc
6.6.1 AstraZeneca plc Corporation Information
6.6.2 AstraZeneca plc Description and Business Overview
6.6.3 AstraZeneca plc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca plc Asthma Medication Product Portfolio
6.6.5 AstraZeneca plc Recent Developments/Updates
6.7 Roche Holdings Ltd
6.6.1 Roche Holdings Ltd Corporation Information
6.6.2 Roche Holdings Ltd Description and Business Overview
6.6.3 Roche Holdings Ltd Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Holdings Ltd Asthma Medication Product Portfolio
6.7.5 Roche Holdings Ltd Recent Developments/Updates
6.8 Genentech Inc
6.8.1 Genentech Inc Corporation Information
6.8.2 Genentech Inc Description and Business Overview
6.8.3 Genentech Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Genentech Inc Asthma Medication Product Portfolio
6.8.5 Genentech Inc Recent Developments/Updates
6.9 Sepracor, Inc
6.9.1 Sepracor, Inc Corporation Information
6.9.2 Sepracor, Inc Description and Business Overview
6.9.3 Sepracor, Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Sepracor, Inc Asthma Medication Product Portfolio
6.9.5 Sepracor, Inc Recent Developments/Updates
6.10 Schering-Plough Corp
6.10.1 Schering-Plough Corp Corporation Information
6.10.2 Schering-Plough Corp Description and Business Overview
6.10.3 Schering-Plough Corp Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Schering-Plough Corp Asthma Medication Product Portfolio
6.10.5 Schering-Plough Corp Recent Developments/Updates
6.11 Sanofi-Aventis
6.11.1 Sanofi-Aventis Corporation Information
6.11.2 Sanofi-Aventis Asthma Medication Description and Business Overview
6.11.3 Sanofi-Aventis Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sanofi-Aventis Asthma Medication Product Portfolio
6.11.5 Sanofi-Aventis Recent Developments/Updates
6.12 Theravance Inc
6.12.1 Theravance Inc Corporation Information
6.12.2 Theravance Inc Asthma Medication Description and Business Overview
6.12.3 Theravance Inc Asthma Medication Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Theravance Inc Asthma Medication Product Portfolio
6.12.5 Theravance Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Asthma Medication Industry Chain Analysis
7.2 Asthma Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Asthma Medication Production Mode & Process
7.4 Asthma Medication Sales and Marketing
7.4.1 Asthma Medication Sales Channels
7.4.2 Asthma Medication Distributors
7.5 Asthma Medication Customers
8 Asthma Medication Market Dynamics
8.1 Asthma Medication Industry Trends
8.2 Asthma Medication Market Drivers
8.3 Asthma Medication Market Challenges
8.4 Asthma Medication Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Dulera
QVAR
Glaxosmithkline plc
MAP Pharmaceuticals锛孖nc
Merck & Co. Inc
AstraZeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
Theravance Inc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂